Gross Margin
1.97%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives -2.03%.Updated Aug 19, 2026Profit Margin
-8.17%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Margin
-6.57%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Assets (TTM)
-3.73%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Equity (TTM)
-9.70%vs Specialty Chemicals peers Updated Aug 19, 2026Revenue (TTM)
9.43BTWD295.27M · vs all stocks (USD) Updated Aug 19, 2026Revenue per Share (TTM)
16.23TWDUpdated Aug 19, 2026Quarterly Revenue Growth
8.60%vs Specialty Chemicals peers Updated Aug 19, 2026Gross Profit (TTM)
-191.75MTWD-6.00M · vs all stocks (USD) Updated Aug 19, 2026EBITDA (TTM)
-271.44MTWD-8.50M · vs all stocks (USD) Updated Aug 19, 2026Net Income (TTM)
-770.90MTWD-24.13M · vs all stocks (USD) Updated Aug 19, 2026Quarterly Earnings Growth (YoY)
8.60%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Cash Flow (TTM)
327.11MTWD10.24M · vs all stocks (USD) Updated Aug 19, 2026Levered Free Cash Flow (TTM)
-1.71BTWD-53.40M · vs all stocks (USD) Updated Aug 19, 2026Trailing Annual Dividend Rate
0.1000TWDUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.85%Updated Aug 19, 20265-Year Average Dividend Yield
4.04%Updated Aug 19, 2026Payout Ratio
100.00%vs Specialty Chemicals peers Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -7.52%.Updated Aug 19, 2026Minority Interest (Equity)
512.41MTWDFY2025 · Dec 31, 2025Revenue
9.22BTWDFY2025 · Dec 31, 2025Cost of Goods Sold
9.57BTWDFY2025 · Dec 31, 2025Gross Profit
-349.92MTWDFY2025 · Dec 31, 2025Operating Income
-1.26BTWD-39.44M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-1.33BTWDFY2025 · Dec 31, 2025Income Tax Expense
-345.06MTWDFY2025 · Dec 31, 2025Net Income
-982.23MTWDFY2025 · Dec 31, 2025EBIT
-1.22BTWDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-389.02MTWDFY2025 · Dec 31, 2025Research & Development
34.70MTWDFY2025 · Dec 31, 2025Selling, General & Administrative
875.33MTWDFY2025 · Dec 31, 2025Non-operating Interest Income
27.31MTWDFY2025 · Dec 31, 2025Non-operating Interest Expense
110.24MTWDFY2025 · Dec 31, 2025Minority Interests (P&L)
63.25MTWDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TWDFY2025 · Dec 31, 2025Operating Cash Flow
-372.89MTWDFY2025 · Dec 31, 2025Free Cash Flow
-2.38BTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
512.42MTWDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-1.33BTWDFY2025 · Dec 31, 2025Other Non-cash Items
82.93MTWDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
37.75MTWDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
833.72MTWDFY2025 · Dec 31, 2025Capital Expenditures
-2.01BTWDFY2025 · Dec 31, 2025Net Intangibles (CF)
-103.00KTWDFY2025 · Dec 31, 2025Purchase of Investments
-1.33BTWDFY2025 · Dec 31, 2025Sale of Investments
1.77BTWDFY2025 · Dec 31, 2025Other Investing Activity
-78.84MTWDFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.64BTWDFY2025 · Dec 31, 2025Long-term Debt Issuance
3.21BTWDFY2025 · Dec 31, 2025Long-term Debt Payments
-2.13BTWDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-820.00MTWDFY2025 · Dec 31, 2025Common Dividends Paid
-86.49MTWDFY2025 · Dec 31, 2025Other Financing Charges
2.78MTWDFY2025 · Dec 31, 2025Net Financing Cash Flow
175.29MTWDFY2025 · Dec 31, 2025